Release #:812-183245-rl-1235735: Global Non-Opioi
Post# of 8405
(Total Views: 528)
Posted On: 09/03/2019 10:01:57 AM
Release #:812-183245-rl-1235735:
Global Non-Opioid Pain Relief Device Market, 2018-2029
DUBLIN, Aug. 30, 2019 /PRNewswire/ -- The "Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape - Analysis and Forecast, 2018-2029" report is available.
In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029. The market is primarily driven by increasing government regulations and higher incidences of chronic pain.
The overall global non-opioid pain relief device market has witnessed steady growth. The market is expected to continue to grow with a CAGR of 8.26% during the forecast period. However, limited products available and limited awareness regarding them act as challenges that may affect the steady growth of the market
Key Companies in the Market
The key players in the global non-opioid pain relief device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Stryker, Nuvectra Corporation, Omron Corporation, Neurometrix, Inc, Calmare Therapeutics Incorporated, Bayer AG, Bioelectronics Corporation, Zynex Medical, SPR Therapeutics, AAND Stimwave LLC, Thermotek Inc.
Market Overview
The rising trend of a sedentary lifestyle and the growing geriatric population have led to the emergence of chronic pain disorders. Multiple chronic pain conditions including neurological and musculoskeletal disorders act as leading contributors to the global non-opioid pain relief device market. These factors have become the primary drivers for the non-opioid pain relief device market.
The market is further expected to proliferate at a rapid pace owing to the increased side effects of opioid medications for pain management, which further promote the early adoption of non-opioid pain relief medical devices among people of all age groups. Moreover, a limited success rate of drugs targeting a specific disease is further facilitating the growth of the market.
Expert Quote
North America held the largest market share in 2018 and constitutes over 39.5% of the revenue share owing to increased incidences of chronic pain as well as a higher proliferation of regulations and standards in different parts of the world. However, Asia-Pacific is projected to be the fastest-growing region and is anticipated to grow at a CAGR of over 9.9% from 2019 to 2029.
9/3/2019 9:28:45 AM
Global Non-Opioid Pain Relief Device Market, 2018-2029
DUBLIN, Aug. 30, 2019 /PRNewswire/ -- The "Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape - Analysis and Forecast, 2018-2029" report is available.
In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029. The market is primarily driven by increasing government regulations and higher incidences of chronic pain.
The overall global non-opioid pain relief device market has witnessed steady growth. The market is expected to continue to grow with a CAGR of 8.26% during the forecast period. However, limited products available and limited awareness regarding them act as challenges that may affect the steady growth of the market
Key Companies in the Market
The key players in the global non-opioid pain relief device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Stryker, Nuvectra Corporation, Omron Corporation, Neurometrix, Inc, Calmare Therapeutics Incorporated, Bayer AG, Bioelectronics Corporation, Zynex Medical, SPR Therapeutics, AAND Stimwave LLC, Thermotek Inc.
Market Overview
The rising trend of a sedentary lifestyle and the growing geriatric population have led to the emergence of chronic pain disorders. Multiple chronic pain conditions including neurological and musculoskeletal disorders act as leading contributors to the global non-opioid pain relief device market. These factors have become the primary drivers for the non-opioid pain relief device market.
The market is further expected to proliferate at a rapid pace owing to the increased side effects of opioid medications for pain management, which further promote the early adoption of non-opioid pain relief medical devices among people of all age groups. Moreover, a limited success rate of drugs targeting a specific disease is further facilitating the growth of the market.
Expert Quote
North America held the largest market share in 2018 and constitutes over 39.5% of the revenue share owing to increased incidences of chronic pain as well as a higher proliferation of regulations and standards in different parts of the world. However, Asia-Pacific is projected to be the fastest-growing region and is anticipated to grow at a CAGR of over 9.9% from 2019 to 2029.
9/3/2019 9:28:45 AM
(0)
(0)